| 证券代码：605166 | 证券简称：聚合顺 | 公告编号：2025-051 | | --- | --- | --- | | 转债代码：111003 | 转债简称：聚合转债 | | | 转债代码：111020 | 转债简称：合顺转债 | | 聚合顺新材料股份有限公司 2024年年度股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 (四) 表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次股东大会采取现场记名投票表决与网络投票表决相结合的方式召开。会 议由公司董事会提议召开，董事长傅昌宝先生主持会议。 (三) 出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： 1、出席会议的股东和代理人人数 175 2、出席会议的股东所持有表决权的股份总数（股） 129,353,187 3、出席会议的股东所持有表决权股份数占公司有表决权股 份总数的比例（%） 41.1002 (一) 股东大会召开的时间：2025 年 4 月 ...

浙江金道律师事务所 关于聚合顺新材料股份有限公司 2024 年年度股东大会的 法律意见书 地址：杭州市文二路 391 号西湖国际科技大厦 A 楼 9-12 层 邮编：310012 电话：0571-87006666 传真：0571-87006661 网址：www.zjblf.com 二〇二五年四月 浙江金道律师事务所法律意见书 浙江金道律师事务所 关于聚合顺新材料股份有限公司 2024 年年度股东大会的 法律意见书 致：聚合顺新材料股份有限公司 浙江金道律师事务所（以下简称"本所"）接受聚合顺新材料股份有限公司（以 下简称"公司"）委托，就公司召开 2024 年年度股东大会（以下简称"本次股东大 会"）的有关事宜，根据《中华人民共和国公司法》（以下简称"《公司法》"）、 《中华人民共和国证券法》（以下简称"《证券法》"）、《上市公司股东会规则》 等法律、法规和其他规范性文件以及《聚合顺新材料股份有限公司章程》（以下 简称"公司章程"）的有关规定，出具本法律意见书。 本法律意见书仅供公司 2024 年年度股东大会之目的使用，本所律师同意将 本法律意见书随公司本次股东大会其他信息披露资料一并公告。 为出具本法律意见 ...

聚合顺新材料股份有限公司 关于 2024 年度暨 2025 年第一季度业绩 暨现金分红说明会召开情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 聚合顺新材料股份有限公司（以下简称"公司"）已于 2025 年 4 月 10 日、 2025 年 4 月 26 日发布公司 2024 年年度报告、2025 年第一季度报告。为便于广 大投资者更深入、全面地了解公司经营情况，公司于 2025 年 4 月 29 日召开了 "2024 年度暨 2025 年第一季度业绩暨现金分红说明会"。现将会议召开情况公 告如下： 一、业绩说明会召开基本情况 2025 年 4 月 29 日 16:00-17:00，公司通过上海证券交易所上证路演中心（网 址：http://roadshow.sseinfo.com/）以网络方式召开了"2024 年度暨 2025 年 第一季度业绩暨现金分红说明会"。公司董事长傅昌宝先生、总经理毛新华先生、 财务总监姚双燕女士、董事会秘书陈晓雯女士、独立董事周明生先生、韩林静女 士、尹德军先生出席了本次说明会并与投资者 ...

Investment Rating - The investment rating for the company is "Buy" and is maintained [9]. Core Views - The company reported a revenue of 1.563 billion yuan in Q1 2025, a year-on-year decrease of 4.63% and a quarter-on-quarter decrease of 14.85%. However, the net profit attributable to the parent company was 81 million yuan, showing a year-on-year increase of 15.04% and a quarter-on-quarter increase of 21.16% [2][6]. - The company is focused on the mid-to-high-end nylon chip market, with rapid growth in capacity and performance. The production capacity is distributed across four major bases, with several new projects expected to come online in the next two years [11]. - The price difference for PA6 products improved year-on-year in Q1 2025, despite a decline compared to the previous quarter. The average market price of caprolactam in East China was 10,521 yuan per ton, down 21.83% year-on-year and 3.80% quarter-on-quarter [11]. - The demand for PA6 is expected to grow significantly due to trends in outdoor economy and lightweight automotive applications. The supply side is also entering a new round of rapid capacity expansion, with PA6 capacity expected to reach 7.87 million tons, a year-on-year increase of 24% [11]. - The company is also looking to expand into the PA66 market, which has potential demand growth due to technological breakthroughs and is expected to complement its existing PA6 product line [11]. - The projected net profits for the company from 2025 to 2027 are 410 million yuan, 520 million yuan, and 580 million yuan, respectively, with corresponding PE ratios of 8.6X, 6.8X, and 6.1X [11]. Summary by Sections Financial Performance - Q1 2025 revenue was 1.563 billion yuan, down 4.63% year-on-year and down 14.85% quarter-on-quarter. Net profit attributable to the parent company was 81 million yuan, up 15.04% year-on-year and up 21.16% quarter-on-quarter [2][6]. Company Overview - The company specializes in the mid-to-high-end nylon chip market, with production capacity distributed across four bases. New projects are expected to contribute to growth in the next two years [11]. Market Dynamics - The price difference for PA6 products improved year-on-year, with significant changes in raw material prices impacting profitability. The demand for PA6 is expected to rise due to various industry trends [11]. Future Outlook - The company anticipates continued growth in net profits and is strategically positioning itself in the PA66 market to leverage potential demand [11].

聚合顺新材料股份有限公司 关于股东大会开设网络投票提示服务的公告 | 证券代码：605166 | 证券简称：聚合顺 | 公告编号：2025-049 | | --- | --- | --- | | 转债代码：111003 | 转债简称：聚合转债 | | | 转债代码：111020 | 转债简称：合顺转债 | | 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 聚合顺新材料股份有限公司(以下简称"公司")拟于2025年4月30日14:00 召开2024年年度股东大会，本次会议采用现场投票和网络投票相结合的表决方 式 。 具 体 内 容 详 见 公 司 于 2025 年 4 月 10 日 在 上 海 证 券 交 易 所 网 站 （www.sse.com.cn）及相关指定媒体披露的《聚合顺新材料股份有限公司关于 召开2024年年度股东大会的通知》（公告编号：2025-038）。 为更好地服务广大中小投资者，确保有投票意愿的中小投资者能够及时参 会、便利投票。公司拟使用上证所信息网络有限公司（以下简称"上证信息"） 提供的股东会提醒服务 ...

聚合顺新材料股份有限公司 | 证券代码：605166 | 证券简称：聚合顺 | 公告编号：2025-048 | | --- | --- | --- | | 转债代码：111003 | 转债简称：聚合转债 | | | 转债代码：111020 | 转债简称：合顺转债 | | 关于收购山东聚合顺鲁化新材料有限公司部分股权 暨关联交易的进展公告 注：上述相关主体股权变更前的认缴出资额均已于2020年12月实缴完毕。 特此公告。 二、本次关联交易事项进展情况 近日，聚合顺鲁化已完成相关工商变更登记手续。前述工商变更登记完成 后，公司持有聚合顺鲁化65%的股权，具体股权变更情况如下： 单位：万元 | 股东名称 | 变更前 | | 变更后 | | | --- | --- | --- | --- | --- | | | 认缴出资额 | 持股比例 | 认缴出资额 | 持股比例 | | 聚合顺新材料股份有 | 20,400 | 51% | 26,000 | 65% | | --- | --- | --- | --- | --- | | 限公司 | | | | | | 兖矿鲁南化工有限公 | 14,000 | 35% | 14,0 ...

Investment Rating - The report maintains an "Outperform" rating for the company [1] Core Views - The company's Q1 2025 performance met expectations, with total revenue of 1.563 billion yuan, a year-over-year decrease of 4.6%, but a quarter-over-quarter increase of 15% [6] - The production at the Tengzhou base has driven sales growth and improved profitability, with nylon chip sales reaching 142,700 tons in Q1 2025, an 18% year-over-year increase [6] - The company is positioned to benefit from the high demand for nylon, particularly in the textile and automotive sectors, as it continues to replace polyester in various applications [6] Financial Data and Profit Forecast - Projected total revenue for 2025 is 9.284 billion yuan, with a year-over-year growth rate of 29.5% [5] - Expected net profit attributable to the parent company for 2025 is 410 million yuan, reflecting a 36.7% year-over-year increase [5] - Earnings per share (EPS) is forecasted to be 1.30 yuan for 2025, with a projected price-to-earnings (PE) ratio of 9 [5] Production and Market Position - The company has a current production capacity of 582,000 tons per year for PA6 chips, with an additional 364,000 tons under construction [6] - The company is collaborating with China Tianchen to develop PA66, aiming for a long-term capacity of 500,000 tons [6] - The company’s product quality is leading in the domestic market, allowing for premium pricing and a competitive edge [6]

Core Viewpoint - The announcement from 聚合顺新材料股份有限公司 emphasizes the accuracy and completeness of the quarterly report, ensuring no false statements or omissions exist [2][6]. Financial Data Summary - The financial statements for the first quarter of 2025 have not been audited [2][6]. - The report includes major accounting data and financial indicators, although specific figures are not provided in the text [2][6]. Shareholder Information - The report mentions the total number of ordinary shareholders and the status of the top ten shareholders, but specific details are not disclosed [3][4]. Operational Highlights - The company has reported its main products' production, sales, and revenue achievements for the first quarter of 2025, although specific figures are not included in the text [6][7]. - There are no significant events affecting the company's production and operations during the reporting period [7]. Compliance and Responsibility - The board of directors and senior management affirm their legal responsibility for the report's content, ensuring its truthfulness and completeness [2][6].

Financial Performance - The company's operating revenue for Q1 2025 was CNY 1,562,641,215.60, a decrease of 4.63% compared to the same period last year[4] - Net profit attributable to shareholders increased by 15.04% to CNY 80,786,922.02, driven by higher product sales[4] - The net profit after deducting non-recurring gains and losses rose by 19.31% to CNY 76,677,215.59, also due to increased sales volume[4] - Basic earnings per share increased by 18.18% to CNY 0.26, reflecting the growth in net profit[4] - The total profit for Q1 2025 was CNY 97,590,572.56, up from CNY 94,263,987.07 in Q1 2024, reflecting a growth of 3.5%[18] - The net profit attributable to the parent company's shareholders for Q1 2025 was CNY 80,786,922.02, an increase of 15.5% compared to CNY 70,224,824.17 in Q1 2024[19] Cash Flow and Liquidity - The cash flow from operating activities turned positive with a net amount of CNY 29,909,876.48, a significant recovery from a negative cash flow in the previous year[4] - The net cash flow from operating activities for Q1 2025 was CNY 29,909,876.48, a significant improvement from a net outflow of CNY 313,508,662.30 in Q1 2024[22] - The total cash and cash equivalents at the end of Q1 2025 were CNY 1,068,649,297.22, compared to CNY 862,916,621.89 at the end of Q1 2024, showing a year-over-year increase of 23.9%[23] - The company reported a decrease in cash and cash equivalents to RMB 2,499,395,254.81 as of March 31, 2025, down from RMB 2,764,636,931.51 at the end of 2024, a decline of about 9.6%[13] Assets and Liabilities - The total assets at the end of the reporting period were CNY 6,216,879,237.55, an increase of 1.96% from the previous year[5] - Current assets as of March 31, 2025, totaled RMB 4,292,099,130.43, slightly up from RMB 4,251,557,289.65 at the end of 2024[13] - Non-current assets totaled RMB 1,924,780,107.12 as of March 31, 2025, compared to RMB 1,845,913,863.68 at the end of 2024, indicating a growth of about 4.3%[14] - Total liabilities increased to RMB 4,045,603,046.61 in Q1 2025 from RMB 3,894,162,079.88 in Q4 2024, representing an increase of approximately 3.9%[15] - The company's total assets reached RMB 6,216,879,237.55 as of March 31, 2025, up from RMB 6,097,471,153.33 at the end of 2024, reflecting a growth of about 2.0%[14] Operating Costs and Expenses - Total operating costs for Q1 2025 were RMB 1,483,646,543.66, down 4.8% from RMB 1,558,546,056.52 in Q1 2024[17] - Operating costs specifically decreased from RMB 1,508,399,538.84 in Q1 2024 to RMB 1,435,007,079.45 in Q1 2025, reflecting a reduction of approximately 4.8%[17] - The company reported a decrease in sales expenses to CNY 2,872,227.12 in Q1 2025 from CNY 2,226,687.29 in Q1 2024, reflecting a strategic reduction in costs[18] - Research and development expenses for Q1 2025 were CNY 44,477,629.91, slightly down from CNY 46,693,567.55 in Q1 2024, indicating a focus on cost management[18] - The company incurred financial expenses of CNY -11,288,721.42 in Q1 2025, slightly higher than CNY -11,213,069.55 in Q1 2024, indicating stable financial management[18] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 15,120, indicating a stable shareholder base[10] Revenue Trends - Sales revenue from goods and services received in Q1 2025 was CNY 1,123,929,370.42, down from CNY 1,309,937,900.42 in Q1 2024, indicating a decline of 14.2%[22] - The decline in operating revenue was primarily attributed to a significant drop in the price of key raw material caprolactam compared to the previous year[8] Government Support - The company received government subsidies amounting to CNY 5,075,062.16, which positively impacted the financial results[6]

一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 0.2600 | 0.2200 | 18.18 | 0.1600 | | 每股净资产（元） | 6.14 | 5.56 | 10.43 | 5.08 | | 每股公积金(元) | 1.46 | 1.59 | -8.18 | 1.59 | | 每股未分配利润(元) | 3.26 | 2.64 | 23.48 | 2.22 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 15.63 | 16.39 | -4.64 | 12.75 | | 净利润(亿元) | 0.81 | 0.7 | 15.71 | 0.5 | | 净资产收益率(%) | 4.11 | 4.02 | 2.24 | 3.12 | 数据四舍五入，查看更多财务数据>> 二、前10名无限售条件股东持股情况 前十大流通股东累计持有： 14079.6万股，累计占流通股比： 44.73%，较 ...